Last $0.16 USD
Change Today 0.00 / 0.00%
Volume 0.0
SGTI On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/11/14 All times are local (Market data is delayed by at least 15 minutes).

shengtai pharmaceutical inc (SGTI) Snapshot

Open
$0.16
Previous Close
$0.16
Day High
$0.16
Day Low
$0.16
52 Week High
03/14/14 - $1.50
52 Week Low
09/27/13 - $0.10
Market Cap
1.5M
Average Volume 10 Days
1.2K
EPS TTM
$0.08
Shares Outstanding
9.6M
EX-Date
--
P/E TM
2.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for SHENGTAI PHARMACEUTICAL INC (SGTI)

Related News

No related news articles were found.

shengtai pharmaceutical inc (SGTI) Related Businessweek News

No Related Businessweek News Found

shengtai pharmaceutical inc (SGTI) Details

Shengtai Pharmaceutical, Inc., through its subsidiaries, engages in the manufacture and distribution of glucose and starch products in the People’s Republic of China and internationally. The company provides pharmaceutical and medical grade products, including dextrose monohydrate, dextrose anhydrous, dextrin, and pharmaceutical grade cornstarch; and rough glucose, dextrose monohydrate oral, and food and beverage grade cornstarch for the food and beverage, and processing industries. It also offers other products comprising fibers, corn embryo, protein powder, mother liquid, and abamectin ointment. The company markets its products directly to healthcare institutions, medical supply companies, pharmaceutical companies, medical supply exporters, and food and beverage companies. Shengtai Pharmaceutical, Inc. was incorporated in 2004 and is based in Changle County, the People’s Republic of China.

733 Employees
Last Reported Date: 09/28/12
Founded in 2004

shengtai pharmaceutical inc (SGTI) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $19.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $14.3K
Compensation as of Fiscal Year 2012.

shengtai pharmaceutical inc (SGTI) Key Developments

Shengtai Pharmaceutical Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2013

Shengtai Pharmaceutical Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2013. For the quarter, the company's net sales were $49,723,426, an increase of $9,919,818 or 24.92%, compared with $39,803,608 for the same period in 2012. The increase in net sales primarily resulted from increased sales of cornstarch products and other products as well as from increased exports for the three months ended March 31, 2013, compared to the same period in 2012. Net income for the quarter was $105,218 or $0.01 per basic and diluted share compared with net income of $98,253 or $0.01 per basic and diluted share for the same period in 2012. The increase in net income was primarily attributable to the decreased interest expenses of $764,190 and increased interest income of $25,071. Income from operations was $1,487,345 compared with $2,111,140 a year ago. Income before provision for income taxes was $162,487 compared with $152,375 a year ago. For the nine months, the company's net sales were $162,571,689 compared with $122,792,481 a year ago. Income from operations was $5,345,580 compared with $4,358,141 a year ago. Income before provision for income taxes was $835,869 compared with $1,355,338 a year ago. Net income was $562,735 or $0.06 per basic and diluted share compared with $916,748 or $0.10 per basic and diluted share a year ago. Net cash used in operating activities was $4,398,469 compared with $10,391,666 a year ago. Purchase of plant and equipment was $4,276 compared with $1,227 a year ago.

Shengtai Pharmaceutical Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2012

Shengtai Pharmaceutical Inc. announced unaudited consolidated earnings results for the second quarter and six months ended December 31, 2012. For the quarter, the company reported net sales of $64,103,621 compared to $42,933,425 a year ago. Income from operations was $2,089,954 compared to $1,014,569 a year ago. Income before provision for income taxes was $380,755 compared to loss before provision for income taxes of $48,983 a year ago. Net income was $261,216 or $0.03 per basic and diluted share compared to net loss of $65,062 or $0.01 per basic and diluted share a year ago. The increase in net sales primarily resulted from increased cornstarch and other products sales. The increase in net income was primarily attributable to the increased gross profit of $1,947,768, offset by increased selling, general and administrative expenses of $872,383 and by increased interest expenses of $518,770. For the six months, the company reported net sales of $112,848,264 compared to $82,988,873 a year ago. Income from operations was $3,858,235 compared to $2,247,001 a year ago. Income before provision for income taxes was $673,382 compared to $1,202,963 a year ago. Net income was $457,517 or $0.05 per basic and diluted share compared to $818,495 or $0.09 per basic and diluted share a year ago. Net cash provided by operating activities was $1,285,014 compared to net cash used in operating activities of $9,539,722 a year ago. Purchase of plant and equipment was $4,259 compared to $1,221 a year ago.

Shengtai Pharmaceutical Inc. Deleted From OTCBB

Shengtai Pharmaceutical Inc.'s common stock has been deleted from OTC Bulletin Board (OTCBB) effective January 15, 2013, on account of ineligible for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGTI:US $0.16 USD 0.00

SGTI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SGTI.
View Industry Companies
 

Industry Analysis

SGTI

Industry Average

Valuation SGTI Industry Range
Price/Earnings 2.1x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 2.1x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHENGTAI PHARMACEUTICAL INC, please visit www.shengtaipharmaceutical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.